000 01381 a2200481 4500
005 20250512210248.0
264 0 _c19840712
008 198407s 0 0 eng d
022 _a0013-9580
024 7 _a10.1111/j.1528-1157.1984.tb04205.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKalff, R
245 0 0 _aCarbamazepine and serum sodium levels.
_h[electronic resource]
260 _bEpilepsia
_cJun 1984
300 _a390-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAging
650 0 4 _aArginine Vasopressin
_xurine
650 0 4 _aCarbamazepine
_xadverse effects
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCyclic AMP
_xanalysis
650 0 4 _aEpilepsy
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHyponatremia
_xchemically induced
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
650 0 4 _aSodium
_xblood
650 0 4 _aTime Factors
700 1 _aHoutkooper, M A
700 1 _aMeyer, J W
700 1 _aGoedhart, D M
700 1 _aAugusteijn, R
700 1 _aMeinardi, H
773 0 _tEpilepsia
_gvol. 25
_gno. 3
_gp. 390-7
856 4 0 _uhttps://doi.org/10.1111/j.1528-1157.1984.tb04205.x
_zAvailable from publisher's website
999 _c6327175
_d6327175